NasdaqGS:IRTCMedical Equipment
iRhythm Technologies (IRTC) Faces Growing Losses as Revenue Growth Outpaces US Market Expectations
iRhythm Technologies (IRTC) is expected to deliver revenue growth of 14.3% per year, outpacing the broader US market’s 10.3% growth rate. While the company remains unprofitable at present, earnings are projected to climb rapidly at a 74.62% annual pace with profitability on the horizon within the next three years. Investors are weighing these strong growth prospects against the fact that losses have actually increased by 12.5% per year over the past five years, setting up high expectations...